Literature DB >> 15071006

Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus.

Liqun Lu1, Ivanus Manopo, Bernard P Leung, Hiok Hee Chng, Ai Ee Ling, Li Lian Chee, Eng Eong Ooi, Shzu-Wei Chan, Jimmy Kwang.   

Abstract

Severe acute respiratory syndrome (SARS) is a novel infectious disease caused by the SARS-associated coronavirus (SARS-CoV). There are four major structural proteins in the SARS-CoV, including the nucleocapsid, spike, membrane, and small envelope proteins. In this study, two sets of truncated fragments of spike protein were generated, the first were approximately 210-bp nonoverlapping fragments and the second were overlapping segments of 750 to 900 bp. From these 23 fragments, we identified a fragment of 259 amino acids (amino acids 441 to 700) that is a major immunodominant epitope. This fragment was highly expressed, and the purified fragment C could detect all 33 SARS patient serum samples tested, collected from 7 to 60 days after the onset of fever, but had no reactivity with all 66 healthy human serum samples tested. Thus, fragment C of spike protein was identified as an immunodominant antigen and could be used for serological detection of SARS-CoV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071006      PMCID: PMC387621          DOI: 10.1128/JCM.42.4.1570-1576.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

2.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

3.  Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.

Authors:  L Kuo; G J Godeke; M J Raamsman; P S Masters; P J Rottier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

5.  Identification of severe acute respiratory syndrome in Canada.

Authors:  Susan M Poutanen; Donald E Low; Bonnie Henry; Sandy Finkelstein; David Rose; Karen Green; Raymond Tellier; Ryan Draker; Dena Adachi; Melissa Ayers; Adrienne K Chan; Danuta M Skowronski; Irving Salit; Andrew E Simor; Arthur S Slutsky; Patrick W Doyle; Mel Krajden; Martin Petric; Robert C Brunham; Allison J McGeer
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

6.  Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge.

Authors:  L Yu; W Liu; W M Schnitzlein; D N Tripathy; J Kwang
Journal:  Avian Dis       Date:  2001 Apr-Jun       Impact factor: 1.577

7.  Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence.

Authors:  J J Phillips; M M Chua; E Lavi; S R Weiss
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 8.  Coronavirus spike proteins in viral entry and pathogenesis.

Authors:  T M Gallagher; M J Buchmeier
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

9.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

10.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

View more
  37 in total

1.  Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus.

Authors:  Yuxian He; Yusen Zhou; Pamela Siddiqui; Jinkui Niu; Shibo Jiang
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients.

Authors:  S C S Chow; C Y S Ho; T T Y Tam; C Wu; T Cheung; P K S Chan; M H L Ng; P K Hui; H K Ng; D M Y Au; A W I Lo
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

3.  Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.

Authors:  Jianhua Sui; Meagan Deming; Barry Rockx; Robert C Liddington; Quan Karen Zhu; Ralph S Baric; Wayne A Marasco
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

4.  Simultaneous detection of antibodies to mouse hepatitis virus recombinant structural proteins by a microsphere-based multiplex fluorescence immunoassay.

Authors:  Satoshi Kunita; Kanako Kato; Miyuki Ishida; Kozue Hagiwara; Shuko Kameda; Tomoko Ishida; Akira Takakura; Kazuo Goto; Fumihiro Sugiyama; Ken-Ichi Yagami
Journal:  Clin Vaccine Immunol       Date:  2011-03-23

5.  Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.

Authors:  Jincun Zhao; Wei Wang; Wenling Wang; Zhendong Zhao; Yan Zhang; Ping Lv; Furong Ren; Xiao-Ming Gao
Journal:  Clin Vaccine Immunol       Date:  2007-05-02

6.  Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.

Authors:  Aaron C Petrey; Fares Qeadan; Elizabeth A Middleton; Irina V Pinchuk; Robert A Campbell; Ellen J Beswick
Journal:  J Leukoc Biol       Date:  2020-09-15       Impact factor: 4.962

7.  Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).

Authors:  Mavanur R Suresh; Pravin K Bhatnagar; Dipankar Das
Journal:  J Pharm Pharm Sci       Date:  2008-04-19       Impact factor: 2.327

8.  Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody.

Authors:  Luis G Giménez; Jose Rojas; Almudena Rojas; Joaquín Mendoza; Ana G Camacho
Journal:  Clin Vaccine Immunol       Date:  2008-11-26

9.  Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens.

Authors:  Joshua M DiNapoli; Alexander Kotelkin; Lijuan Yang; Subbiah Elankumaran; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

10.  False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.

Authors:  Mimoun Maache; Florence Komurian-Pradel; Alain Rajoharison; Magali Perret; Jean-Luc Berland; Stéphane Pouzol; Audrey Bagnaud; Blandine Duverger; Jianguo Xu; Antonio Osuna; Glaucia Paranhos-Baccalà
Journal:  Clin Vaccine Immunol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.